PD-ECGF Monoclonal antibody, PBS Only (Capture)

PD-ECGF Monoclonal Antibody for Cytometric bead array, Indirect ELISA
Cat No. 67104-2-PBS
Clone No.1B3E7

Host / Isotype

Mouse / IgG2a

Reactivity

human

Applications

Cytometric bead array, Indirect ELISA

Formulation:  PBS Only
PBS Only
Conjugate:  Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Product Information

67104-2-PBS targets PD-ECGF as part of a matched antibody pair:

MP51270-1: 67104-2-PBS capture and 67104-3-PBS detection (validated in Cytometric bead array)

Unconjugated mouse monoclonal antibody pair in PBS only (BSA and azide free) storage buffer at a concentration of 1 mg/mL, ready for conjugation.

This conjugation ready format makes antibodies ideal for use in many applications including: ELISAs, multiplex assays requiring matched pairs, mass cytometry, and multiplex imaging applications.Antibody use should be optimized by the end user for each application and assay.

Tested Reactivity human
Host / Isotype Mouse / IgG2a
Class Monoclonal
Type Antibody
Immunogen PD-ECGF fusion protein Ag28631 Predict reactive species
Full Name thymidine phosphorylase
Calculated Molecular Weight 482 aa, 50 kDa
GenBank Accession NumberBC018160
Gene Symbol Thymidine phosphorylase
Gene ID (NCBI) 1890
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purification
UNIPROT IDP19971
Storage Buffer PBS only , pH 7.3
Storage ConditionsStore at -80°C.

Background Information

Platelet derived endothelial cell growth factor (PD-ECGF), also known as thymidine phosphorylase (TP), induces migration and angiogenesis in endothelial and tumor cells, and was upregulated in various malignancies compared to that in normal tissues. Interestingly, PD-ECGF has dual effect on tumor development and chemotherapy. It could stimulate cancer cell migration and proliferation. On the other hand, some chemotherapeutic agents (5-fluorouracil, capecitabine, etc.] were converted to their active forms through TP enzymes.

Loading...